The ACR/ARHP Annual Meeting is the premier educational event for physicians, health professionals and scientists who treat those with or at risk for arthritis, rheumatic and musculoskeletal diseases. The annual meeting is a forum for physicians and health professionals to receive the most relevant and latest developments in rheumatology.
Each year, the annual meeting draws thousands of abstracts submitted by rheumatologists and health professionals from around the world. Accepted abstracts are published in an online supplement of the Arthritis & Rheumatology journal and displayed in an international venue.
2015 ACR Call for Late-breaking Abstracts
September 14 – October 6; noon ET
General Abstract Information
Important Abstract Dates:
Abstract Submission Opens: May 4
Abstract Submission Closes: June 23 (noon ET)
Abstract Presenting Author Acceptance/Rejection Notification: Late-August
Late-breaking Abstract Submission Opens: September 14
Late-breaking Abstract Submission Closes: October 6 (noon ET)
Accepted Abstracts Embargo Lifted: November 7 (4:30 PM PT)
Important Registration/Housing Dates:
Members Only Registration/Housing Opens: June 3
Member/Non-member Registration/Housing Opens: June 17
Early-bird Registration/Housing Deadline: August 19
Advance Registration Deadline: October 21
2015 Call for Abstracts will open on Monday, May 4 and close at Noon ET on Tuesday, June 23.
Abstract Embargo and Permissions Policies
Abstract Embargo Policy
Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until 4:30 PM Pacific Time on Saturday, November 7, 2015.
Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at firstname.lastname@example.org.
The annual meeting is a private event. Programs presented at the meeting are for the education of attendees and purchasers of recorded presentations as authorized by the American College of Rheumatology. The information and materials displayed and presented during this meeting are the property of the ACR and the presenter and cannot be photographed, copied, photocopied, transformed to electronic format, reproduced, or distributed without written permission of the American College of Rheumatology and the presenter. Any use of the program content for commercial purposes, which includes, but is not limited to oral presentations, audiovisual materials used by speakers, and program handouts without the written consent of the ACR is prohibited. This policy applies before, during and after the meeting. The ACR will enforce its intellectual property rights and penalize those who infringe upon it.
The names, insignias, logos and acronyms of the ACR, the ARHP and the Rheumatology Research Foundation are proprietary marks. Use of the names in any fashion, by any entity, for any purpose, is prohibited without the express written permission of the American College of Rheumatology. Attendees who have questions about the ACR’s copyright policy should contact the public relations department at email@example.com.
Credentialed media attend the annual meeting to cover stories for consumer, trade and other media outlets, and are easily identified by their black press ribbons. Media has access to all general sessions and limited access (at the discretion of speakers) to Meet the Professor and Workshop sessions. Media may use hand-held audio recorders and still cameras; moving video recording is also permitted with the permission of the presenter(s). The exception to this policy is that no photos or video are allowed in the Exhibit Hall and no photos or video are allowed in the Poster Hall without permission from the poster presenter. Press who would like general photos of the Exhibit Hall can obtain these after the meeting from the ACR. Attendees who have questions about the ACR’s media policies should contact the public relations department at firstname.lastname@example.org.
Photographs and Video Recording Policy
As a courtesy to our presenters, ACR policy does not permit photographs or recordings during educational sessions, including poster sessions. The only exception to this is for registered media, who should review their registration materials for more information.
Abstract Reprint (Reproduction) Policy
Copyright law covers all annual meeting abstracts published by the American College of Rheumatology. All rights reserved. No abstracts may be reproduced in any form or by any means, except as permitted under section 107 and 108 of the 1976 United States Copyright Act, without the prior permission of the publisher.
For the purposes of this statement, the term “ACR Abstracts” refers to all annual meeting abstracts as published in Arthritis & Rheumatology and posted online, including the abstracts accepted for presentation during ARHP sessions and the late-breaking category.
For the purposes of this statement, the term “ACR Posters” refers to the accepted abstract POSTER PRESENTATIONS as presented in the poster hall during the annual meeting. This does not include abstract text published in the online supplement of Arthritis & Rheumatology. All ACR Posters are the property of the ACR or the presenting author and cannot be reproduced or distributed without written permission from the ACR and the presenting author.
For the purposes of this statement, the term “reproduce” includes all forms of reproduction including, but not limited to, print, electronic and photographed formats.
For the purposes of this statement, the term “presenting author” refers to the author who is designated as the individual who will present the work during the ACR annual meeting, as identified through the abstract submission process.
- Excerpts of ACR Abstracts or ACR Poster Presentations in their entirety may not be reproduced without the prior written permission of the publisher.
- Permission requests for abstract content and other permission inquiries should be addressed to:
c/o John Wiley & Sons, Inc.
111 River Street
Hoboken, NJ 07030
Fax: (201) 748-6008
- Commercial entities seeking permission to reprint must obtain all materials from the author and/or publisher John Wiley & Sons, Inc. ACR cannot provide any materials.
Reproducing ACR Abstracts and ACR Posters for Dissemination Prior to the Annual Meeting
- Requests to reproduce abstracts for dissemination prior to the annual meeting will not be approved.
- Per the ACR Embargo Policy, academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract online.
- Permission to issue a press release does not require ACR approval. However, it must comply with the ACR Embargo Policy; violation of this policy may result in the abstract being withdrawn from the meeting or other measures deemed appropriate.
- For more information regarding press releases, please contact the ACR Public Relations Department at email@example.com.
Reproducing ACR Abstracts and ACR Posters for Dissemination During the Annual Meeting
Following approval (see approval process above), an exhibiting organization may:
- Disseminate copies of individual ACR Abstracts from its exhibit space. Booklets of abstracts (e.g., two or more) may not be produced.
- Disseminate information summaries (title/date/time/poster number) of ACR Abstracts from its exhibit space.
- Summaries may not reference company or product names. Requests for approval must be submitted in writing to firstname.lastname@example.org.
- Presenting authors may disseminate individual copies of their ACR Poster during their assigned poster presentation time.
- Dissemination must be limited to the area directly in front of their assigned poster space and may not interfere with other poster presentations.
- An electronic copy of the poster may be provided via a QR code generated by the presenter and included on the poster
Reproducing ACR Abstracts and ACR Posters for Dissemination After the Annual Meeting
Following approval (see approval process above), the ACR permits ACR Abstracts (i.e., all abstract content published in the online supplement) to be reprinted and disseminated following the annual meeting.
- Booklets of abstracts (e.g., two or more) must include the following statement on the front of the booklet:
Abstract(s) reprinted from the ACR/ARHP Annual Meeting held November 6-11, 2015. The American College of Rheumatology does not guarantee, warrant, or endorse any commercial products or services. Reprinted by (insert name of supporting company).
- Booklets cannot contain corporate or product logos or any advertisements. No exceptions.
ACR Poster Presentations
Following approval from the presenting author and ACR, copies of actual ACR poster presentations (i.e. images of the poster presentation hung in the poster hall) may be reproduced.
- Reprint requests for the actual poster abstract text published in the Arthritis & Rheumatology supplement are considered ACR Abstracts and must submitted to Wiley (see approval process above).
- Requests to reproduce individual ACR poster or booklets of poster presentations (e.g., two or more) must be submitted via e-mail to email@example.com.
- Poster reproduction requests must include the following:
- Abstract ID Number
- Abstract Title
- Presenting Author’s Name
- A copy of Presenting Author’s written approval (Please Note: An e-mail approval from Presenting Author is acceptable)
- IMPORTANT: The ACR does not retain and cannot provide poster presentation images.
- The following statement must be listed under each Poster reprint:
Poster reprinted from the ACR/ARHP Annual Meeting held November 6-11, 2015. The American College of Rheumatology does not guarantee, warrant, or endorse any commercial products or services. Reprinted by (insert name of supporting company).
Use of the ACR Disclosure Key
It is suggested when referencing disclosures in the reprints, that the ACR’s disclosure key be added to provide adequate context for abstracts:
None: Nothing to disclose
1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
2. Research grants
3. Employment (full or part-time)
4. Ownership or partnership
5. Consulting fees or other remuneration (payment)
6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
7. Receipt of royalties
8. Speakers’ bureau
Use of the ACR Name
- The names, insignias, logos and acronyms of the ACR, the ARHP and the Rheumatology Research Foundation are proprietary marks.
- Use of the names in any fashion, by any entity, for any purpose, is prohibited without the written permission of the ACR.
Use of the ACR Scientific Program Content
- Information displayed or presented at all sessions during the annual meeting is the property of the ACR or the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced or distributed without the written permission of the ACR and the presenter.
- Any use of the program content, which includes but is not limited to oral presentations, audiovisual materials used by speakers and program handouts, without the written consent of the ACR is prohibited.
- This policy applies before, during and after the meeting.
- The ACR will enforce its intellectual property rights and penalize those who infringe upon it.